Despite the increasing incidence of combined small-cell lung cancer (C-SCLC) in recent
years, there have not been many data on clinical prognostic factors predicting prognosis of …

Background Combined small-cell lung cancer (CSCLC) refers to the simultaneous presence
of small cell lung cancer (SCLC) and any subtype of the non-small cell lung cancer …

Backgrounds Compared to pure small cell lung cancer (SCLC), combined small cell lung
cancer (C-SCLC) has its own characteristics. High neutrophil to lymphocyte ratio (NLR) and …

Aims a) To identify which pretreatment clinical or blood parameters were predictive of patient
survival in small-cell lung cancer (SCLC) in a retrospective analysis. b) To validate three …

We have reviewed the biomedical literature published over the last 25 years in order to try to
establish which of four frequently evaluated laboratory parameters (ie serum, or plasma …

Pretreatment performance status (PS) is a major prognostic factor for both treatment
response and survival duration in cancer clinical trials. PS is, however, a subjective index …

The purposes of this study were to evaluate the treatment outcome of patients with small cell
lung cancer (SCLC), focusing on the prognostic factors for response to therapy and overall …

Background: Small-cell lung cancer (SCLC) presents aggressive clinical behavior, and its
prognosis is still poor. Previously, performance status (PS), or the existence of brain, bone …

Introduction: Comorbidity may be an important prognostic factor in the treatment of small cell
lung carcinoma (SCLC). This study aimed to investigate the prognostic values of simplified …

Introduction Little is known about the prognostic factors for small cell lung cancer (SCLC) in
Chinese patients. Objective The aim of this retrospective study was to improve our …